L. Fodor et al. / Tetrahedron 69 (2013) 410e417
417
ꢀ
powder, mp: 192e193 C, yield 21%, 0.10 g. Anal. Calcd for
0
.12 g. Anal. Calcd for C16
H17Cl
2
NOS (342.28): C, 56.14; H, 5.01; N,
4
.09; S, 9.37. Found: C, 56.30; H, 5.28; N, 4.34; S, 9.54.
19 2
C H25NO S (331.47): C, 68.85; H, 7.60; N, 4.23; S, 9.67. Found: C,
68.66; H, 7.86; N, 4.40; S, 9.98.
5
.6.4.3. (2R
*
,2aS
*
,4aR
*
, 8aR )-2-Chloro-2a-(4-methylphenyl)-2,2a,
*
4
a,5,6,7,8,8a-octahydro-2H,4H-azeto[1,2-a][3,1]benzothiazin-1-one
Acknowledgements
ꢀ
(14c). A white crystalline powder, mp: 156e158 C, yield 16%, 0.15 g.
Anal. Calcd for C17
H
20ClNOS (321.87): C, 63.44; H, 6.26; N, 4.35; S,
The authors express their thanks to the Hungarian Scientific
Research Foundation (OTKA K-83874 and K-68887) for financial
support. The European Union and the European Social Fund also
provided financial support for the project under grant agreement
9
.96. Found: C, 63.65; H, 6.35; N, 4.21; S, 10.31.
5
.7. General procedure for thiazepine derivatives 15aecand16aec
The isomeric mixture of azeto-3,1-thiazines 11aec and 12aec or
ꢀ
no. TAMOP 4.2.1./B-09/KMR-2010-0003.
1
3aec and 14aec (1.5 mmol) was dissolved in ethanol (10 mL). To
References and notes
this stirred solution, sodium ethoxide (100 mg, 1.41 mmol for the
mixture of 11aec and 12aec; 200 mg, 2.82 mmol for the mixture of
1. (a) Alcaide, B.; Almendros, P.; Aragoncillo, C. Curr. Opin. Drug. Discov. Dev. 2010,
13, 685; (b) qysek, R.; Katarzyna Borsuk, K.; Furman, B.; Ka1u
A.; Chmielewski, M. Curr. Med. Chem. 2004, 11, 1813; (c) Deshmukh, A. R. A. S.;
Bhawal, B. M.; Krishnaswamy, D.; Govande, V. V.; Shinkre, B. A.; Jayanthi, A.
Curr. Med. Chem. 2004, 11, 1889; (e) Alcaide, B.; Almendros, P. Curr. Med. Chem.
2004, 11, 1921.
z_ a, Z.; Kazimierski,
1
3aec and 14aec) was added. The reaction mixture was refluxed
for 4 h. After the further addition of sodium ethoxide (100 mg,
.41 mmol), the mixture was next refluxed for 2 h. After cooling
1
down to room temperature, ethyl acetate (40 mL) was added to the
reaction mixture and it was filtered through a thin pad of Celite and
washed with ethyl acetate (40 mL). After evaporation, the residue
was subjected to column chromatography, using n-hexane/ethyl
acetate 9:1, followed by n-hexane/ethyl acetate 4:1 as eluent. After
evaporation of the corresponding fractions, the residues crystal-
lized on trituration with n-hexane (3 mL).
2
. (a) Hocquemiller, A.; Cave, A.; Husson, H.-P. Tetrahedron 1977, 33, 645; (b)
Matsuyama, H.; Kurosawa, A.; Takei, T.; Ohira, N.; Yoshida, M.; Iyoda, M. Chem.
Lett. 2000, 9, 1104; (c) Alcaide, B.; Almendros, P.; Alonso, J. M.; Aly, A. F.; Torres,
M. R. Synlett 2001, 1531.
3. Bose, A. K.; Mathur, C.; Wagle, D. R.; Naqvi, R.; Manhas, M. S. Heterocycles 1994,
39, 491.
4
. Martinek, T. A.; F u€ l o€ p, F. Chem. Soc. Rev. 2012, 41, 687.
5. Kiss, L.; F u€ l o€ p, F. Synlett 2010, 1302.
. (a) Oiarbide, M.; Palomo, C. In Heterocyclic Scaffolds I, b-Lactams; Maes, B. U. W.,
6
Banik, B. K., Eds.; Topics in Heterocyclic Chemistry; Springer: Heidelberg, 2010;
Vol. 22, pp 211e260; (b) D’hooghe, M.; Dekeukeleire, S.; Leemans, E.; De Kimpe,
N. Pure Appl. Chem. 2010, 82, 1749; (c) F u€ l o€ p, F. Chem. Rev. 2001, 101, 2181; Zarei,
M. Bull. Chem. Soc. Jpn. 2012, 85, 360.
. Rao, S. N.; O’Ferrall, R. A. M. J. Org. Chem. 1990, 55, 3244; (b) Van Brabandt, W.;
5
.7.1. (4aR
*
,8aS )-3-Ethoxycarbonyl-2-phenyl-1,5,5a,6,7,8,9,9a-octa-
*
hydro-4,1-benzothiazepine (15a). A yellow crystalline powder, mp:
14e116 C, yield 82%, 0.39 g. Anal. Calcd for C18
8.10; H, 7.30; N, 4.41;S,10.10. Found:C, 68.32;H, 7.21;N, 4.16; S,10.31.
ꢀ
1
6
2
H23NO S (317.45): C,
7
De Kimpe, N. J. Org. Chem. 2005, 70, 3369.
8
9
. Dekeukeleire, S.; D’hooghe, M.; De Kimpe, N. J. Org. Chem. 2009, 74, 1644.
. (a) Begley, M. J.; Crombie, L.; Haigh, D.; Jones, R. C. F.; Osborne, S.; Webster, R.
A. B. J. Chem. Soc., Chem. Commun. 1993, 2027; (b) Banfi, L.; Guanti, G.; Rasparini,
M. Tetrahedron Lett. 1998, 39, 9539.
5
9
.7.2. (4aR ,8aS )-3-Ethoxycarbonyl-2-(4-chlorophenyl)-1,5,5a,6,7,8,-
*
*
,9a-octahydro-4,1-benzothiazepine (15b). A yellow crystalline pow-
der, mp: 157e160 C, yield 61%, 0.32 g. Anal. Calcd for C18
ꢀ
2
H22ClNO S
10. (a) Mollet, K.; D’hooghe, M.; De Kimpe, N. J. Org. Chem. 2011, 76, 264; (b)
D’hooghe, M.; Mollet, K.; Dekeukeleire, S.; De Kimpe, N. Org. Biomol. Chem.
(
4
351.89): C, 61.44; H, 6.30; N, 3.98; S, 9.11. Found: C, 61.80; H, 6.16; N,
.18; S, 9.42.
2010, 8, 607.
1
1. (a) Fodor, L.; Csom oꢀ s, P.; Cs aꢀ mpai, A.; Soh aꢀ r, P. Synthesis 2010, 2943; (b) Csom oꢀ s,
P.; Fodor, L.; Cs ꢀa mpai, A.; Soh ꢀa r, P. Tetrahedron 2010, 66, 3207; (c) Fodor, L.;
Csom oꢀ s, P.; Cs aꢀ mpai, A.; Soh aꢀ r, P. Tetrahedron 2012, 68, 851.
5
9
.7.3. (4aR ,8aS )-3-Ethoxycarbonyl-2-(4-methylphenyl)-1,5,5a,6,7,8,-
*
*
1
2. Simon, L.; Talpas, G. S.; F u€ l o€ p, F.; Bern ꢀa th, G.; Soh ꢀa r, P. Acta Chim. Hung. 1985,
18, 37.
3. (a) Leflemme, N.; Dallemagne, P.; Rault, S. Tetrahedron Lett. 2004, 45, 1503; (b)
Mercey, G.; Br eꢀ geon, D.; Gaumont, A.-C.; Levillain, J.; Gulea, M. Tetrahedron Lett.
008, 49, 6553.
4. (a) Cossío, F. P.; Arrieta, A.; Sierra, M. A. Acc. Chem. Res. 2008, 41, 925; (b) Brandi, A.;
,9a-octahydro-4,1-benzothiazepine (15c). A yellow crystalline pow-
der, mp: 135e137 C, yield 55%, 0.27 g. Anal. Calcd for C19
331.47): C, 68.85; H, 7.60; N, 4.23; S, 9.67. Found: C, 69.16; H, 7.47; N,
.10; S, 9.89.
1
ꢀ
2
H25NO S
1
(
4
2
1
Cicchi, S.; Cordero, F. M. Chem. Rev. 2008, 108, 3988; (c) Xu, J. Arkivoc 2009, ix, 21.
15. Staudinger cycloaddition reactions of regioisomeric cis- and trans-2-aryl-
5
.7.4. (4aR ,8aR )-3-Ethoxycarbonyl-2-phenyl-1,5,5a,6,7,8,9,9a-oc-
*
*
4
(
a,5,6,7,8,8a-hexahydro-4H-1,3-benzothazines provided only one diastereomer
Soh ꢀa r, P.; Szab oꢀ , J.; Simon, L.; Talpas, G. S.; Sz u} cs, E.; Bern aꢀ th, G. Org. Magn.
tahydro-4,1-benzothiazepine (16a). A yellow crystalline powder,
mp: 173e174 C, yield 42%, 0.20 g. Anal. Calcd for C18
317.45): C, 68.10; H, 7.30; N, 4.41; S, 10.10. Found: C, 68.42; H, 7.54;
N, 4.23; S, 10.38.
ꢀ
H23NO
2
S
Reson. 1991, 29, 687 ).
(
16. (a) Palomo, C.; Aizpurua, J. M.; Ganboa, I.; Oiarbide, M. Eur. J. Org. Chem. 1999,
3223; (b) Todorova, A. R.; Kurteva, V. B.; Bontchev, R. P.; Vassilev, N. G. Tetra-
hedron 2009, 65, 10339.
1
7. Soh aꢀ r, P. In Nuclear Magnetic Resonance Spectroscopy; CRC: Boca Raton, FL, 1983;
5
9
.7.5. (4aR
*
,8aR
*
)-3-Ethoxycarbonyl-2-(4-chlorophenyl)-1,5,5a,6,7,8,-
(a) Vol. 2, p 154; (b) Vol. 2, p 25; (c) Vol. 3, pp 4e6; (d) Vol. 1, pp 35e40; (e) Vol.
1, pp 32, 33 and Vol. 2, p 2.
,9a-octahydro-4,1-benzothiazepine (16b). A yellow crystalline pow-
der, mp: 222e225 C, yield 23%, 0.12 g. Anal. Calcd for C18
351.89): C, 61.44; H, 6.30; N, 3.98; S, 9.11. Found: C, 61.65; H, 6.56; N,
ꢀ
18. The numbering in this Part is that prescribed by the IUPAC rule for perhy-
drobenzothiazines (see Scheme 1).
2
H22ClNO S
(
19. (a) Sohar, P.; Gera, L.; Bernath, G. Org. Magn. Reson. 1980, 14, 204; (b) Sohar, P.;
ꢀ ꢀ ꢀ
3
.77; S, 8.91.
F u€ l o€ p, F.; Bern ꢀa th, G. Org. Magn. Reson.1984, 22, 527; (c) Soh aꢀ r, P.; St ꢀa jer, G.; Szab oꢀ ,
A. E.; F u€ l o€ p, F.; Szunyog, J.; Bern aꢀ th, G. J. Chem. Soc., Perkin Trans. 2 1987, 599.
0. F u€ l o€ p, F.; Bern ꢀa th, G.; Argay, G.; K ꢀa lm ꢀa n, A.; Soh aꢀ r, P. Tetrahedron 1984, 40,
2
5.7.6. (4aR
*
,8aR
*
)-3-Ethoxycarbonyl-2-(4-methylphenyl)-1,5,5a,6,7,-
2053.
8,9,9a-octahydro-4,1-benzothiazepine (16c). A yellow crystalline
21. Yadav, V. K.; Babu, K. G. Eur. J. Org. Chem. 2005, 452.